ATNM insider transaction filings

Actinium Pharmaceuticals, Inc. — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-08-20. Screen ATNM transaction legs live →

FiledFormInsiderReported transactionsSource
2025-08-204SETH SANDESH — Chief Executive Officer, DirectorTax withholding (F): 120,900 @ $1.71EDGAR
2025-04-024Chell Jeffrey W. — DirectorDisposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 18,351 (derivative) @ $0 · Disposition to issuer (D): 72,156 (derivative) @ $0 · +1 moreEDGAR
2025-04-024Almenoff June Sherie — DirectorDisposition to issuer (D): 50,000 (derivative) @ $0EDGAR
2025-04-024Nicholson, C. David — DirectorDisposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 18,351 (derivative) @ $0 · +2 moreEDGAR
2025-04-024Shetty Ajit — DirectorDisposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 18,351 (derivative) @ $0 · Disposition to issuer (D): 72,156 (derivative) @ $0 · +1 moreEDGAR
2025-04-024SETH SANDESH — Chief Executive Officer, DirectorDisposition to issuer (D): 16,666 (derivative) @ $0 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 33,333 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 139,062 (derivative) @ $0 · Disposition to issuer (D): 310,182 (derivative) @ $0 · +2 moreEDGAR
2025-04-024O'Loughlin Steve — Chief Financial OfficerDisposition to issuer (D): 3,333 (derivative) @ $0 · Disposition to issuer (D): 1,666 (derivative) @ $0 · Disposition to issuer (D): 3,333 (derivative) @ $0 · Disposition to issuer (D): 8,833 (derivative) @ $0 · Disposition to issuer (D): 13,333 (derivative) @ $0 · Disposition to issuer (D): 59,066 (derivative) @ $0 · +3 moreEDGAR
2025-04-024Steinhart Richard I — DirectorDisposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 18,351 (derivative) @ $0 · +2 moreEDGAR

Recent 8-K events — Actinium Pharmaceuticals, Inc.

FiledFormItems reportedSource
2026-08-148-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K8.01 — Other EventsEDGAR
2026-05-298-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-268-K/A5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-02-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-11-268-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
EDGAR
2025-05-098-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ATNM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →